Treatment for Uterine Cancer

Arisa Kapedani, New Hyde Park, NY
Uterine Cancer
18 - 99

Study Summary

This trial will test the effectiveness of a new chemotherapy regimen for uterine serous carcinoma, which is an aggressive type of endometrial cancer that is difficult to treat.

Eligible Conditions
  • Uterine Cancer

Treatment Effectiveness

Study Objectives

2 Primary · 1 Secondary · Reporting Duration: 2 years post diagnosis

2 years post diagnosis
Feasibility of above regimen in women with advanced stage USC
Incidence of Treatment-related Adverse Events
Week 26
Patient quality of life

Trial Safety

Awards & Highlights

All Individual Drugs Already Approved
Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
Approved for 10 Other Conditions
This treatment demonstrated efficacy for 10 other conditions.
No Placebo Group
All patients enrolled in this trial will receive the new treatment.

Trial Design

0 Treatment Group

0 Treatment Group

Primary Treatment: Treatment · No Placebo Group · Phase 1 & 2

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 2 years post diagnosis

Who is running the clinical trial?

Northwell HealthLead Sponsor
432 Previous Clinical Trials
466,978 Total Patients Enrolled
Karin Shih, MDPrincipal InvestigatorNorthwell Health

Eligibility Criteria

Age 18 - 99 · Female Participants · 0 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:

Frequently Asked Questions

Does this research project allow elderly individuals to participate?

"In order to be included in this clinical trial, patients must be aged 18 to 99. Out of the 3735 total trials, 151 are for people under 18 and 3735 are for patients over 65." - Anonymous Online Contributor

Unverified Answer

Are we able to sign people up for this trial at the moment?

"The information available on does specify that this trial is open and recruiting patients. This particular trial was first posted on May 20th, 2020 with the most recent update being November 16th, 2021. So far, only 17 individuals have been enrolled at a single site." - Anonymous Online Contributor

Unverified Answer

Could you tell me how many people are involved in this clinical trial?

"Yes, the website verifies that this trial is still actively searching for participants. The posting date was May 20th 2020 with the most recent update on November 16th 2021. They are hoping to enroll 17 subjects from a single location." - Anonymous Online Contributor

Unverified Answer

Is this treatment backed by other scientific research?

"There are currently 1229 trials studying this treatment with 343 of them being in Phase 3. The majority of these clinical studies are based in Shanghai, but there are 67003 locations running trials for this treatment." - Anonymous Online Contributor

Unverified Answer

Are there any medical prerequisites for this clinical study?

"Carcinoma patients between the ages of 18 and 99 are encouraged to apply for this clinical trial. In addition to carcinoma, eligible patients must also have definitive USC diagnosis determined by a previous procedure. At the discretion of the surgeon, complete surgical staging should include: total hysterectomy, bilateral salpingo-oophorectomy, peritoneal washings, omental biopsy and lymph node evaluation., ECOG performance status of ≤ 2., Residual disease at completion of surgery of ≤ 1cm by surgeon report., Age > 18 years.." - Anonymous Online Contributor

Unverified Answer

What are the common reasons why this medication is given to patients?

"This medication is frequently used to treat melanoma, but it can also help patients with neoplasm metastasis, lymphoma, non-hodgkin, advanced sarcoma." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.